Body
Year
Recommendation on main indications for clinical use
ASH [2]
1995
Confirm elevated office BP by HBPM. If they disagree confirm by ABPM
CHS [12]
1999
When HBPM is used to assess WCH, the latter should be confirmed by ABPM if available
Australia [13]
1999
Vague recommendations for detecting and following WCH and the treatment effects
FSH [14]
2000
HBPM could be used for screening subjects with office hypertension, but if low ABPM is required. Seems appropriate for following WCH
ESH [15]
2003
Unclear recommendation for detecting and following WCH
JSH [16]
2003
HBPM suitable for the diagnosis of intractable hypertension and WCH and to assess treatment effects
ESH [17]
2004
Can be used as screening method for WCH but requires confirmation by ABPM
AHA [18]
2005
HBPM can be used for initial diagnosis and treatment evaluation
ASH [19]
2008
Use HBPM to confirm office hypertension: If low continue to monitor; if high treat; if borderline confirm by ABPM
2008 2010
HBPM to be used by all treated hypertensives and to detect WCH and MH. If disagrees with ABPM, the latter should probably take precedence
AHA, ASH [21]
2008
HBPM should be reimbursed and routinely used in most patients with known or suspected hypertension. Confirm office hypertension by HBPM: if low continue to monitor; if high treat; if borderline confirm by ABPM
JSH [9]
2012
HBPM is essential for the diagnosis of WCH and MH and extremely effective for the evaluation of drug effects and facilitates long-term BP control
USPSTF [22]
2015
HBPM may be acceptable for confining hypertension (ABPM preferred)
Australia [23]
2015
HBPM can be used to detect WCH and MH and to estimate the effectiveness of treatment
HOPE Asia [24]
2018
Base diagnoses on office BP and HBPM. When they disagree give priority to HBPM and if possible confirm by ABPM
In 1999, the Canadian Hypertension Society adopted a similar approach for the use of HBPM [12], and in 2005 the Canadian Hypertension Education Program included HBPM in their recommended algorithm for the diagnosis of hypertension [25]. In 2006, the UK National Institute for Health and Clinical Excellence (NICE) guidelines for management of hypertension stated that HBPM and ABPM should not be used because their value had not been adequately established and further research was necessary (partial update of NICE clinical guideline 18, June 2006). However, in 2011 the NICE made the landmark recommendation that ABPM is necessary to confirm the diagnosis of hypertension in subjects with office hypertension at stages 1–2, but indicated that HBPM was a suitable alternative in those unable to tolerate ABPM [26]. Meanwhile, other organizations such as the European Society of Hypertension (ESH) [3, 15, 17], the American Heart Association [18], the American Society of Hypertension [19], the French Society of Hypertension [14], the Japanese Society of Hypertension [9, 16], and Australian organizations [13, 23] published scientific statements and guidelines specific for HBPM, in which this method was strongly supported for a major role in the diagnosis and management of hypertension (Table 16.1). In 2008, Thomas Pickering led a joint scientific statement by the American Heart Association and the American Society of Hypertension calling for the wide use of HBPM in most subjects with suspected or treated hypertension and recommended reimbursement for the method [21]. In the same year the ESH Working Group on Blood Pressure Monitoring also published HBPM guidelines which were very much in line with the American ones [3, 21, 27].
Recommendations for using home blood pressure monitoring in the latest American and European guidelines for the management of hypertension
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
